Annual CFI
-$3.13 B
-$1.39 B-80.06%
31 December 2023
Summary:
Abbott Laboratories annual cash flow from investing activities is currently -$3.13 billion, with the most recent change of -$1.39 billion (-80.06%) on 31 December 2023. During the last 3 years, it has fallen by -$918.00 million (-41.44%). ABT annual CFI is now -573.98% below its all-time high of $661.00 million, reached on 31 December 2011.ABT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$594.00 M
-$141.00 M-31.13%
30 September 2024
Summary:
Abbott Laboratories quarterly cash flow from investing activities is currently -$594.00 million, with the most recent change of -$141.00 million (-31.13%) on 30 September 2024. Over the past year, it has increased by +$40.00 million (+6.31%). ABT quarterly CFI is now -133.66% below its all-time high of $1.76 billion, reached on 31 December 2011.ABT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$2.30 B
+$40.00 M+1.71%
30 September 2024
Summary:
Abbott Laboratories TTM cash flow from investing activities is currently -$2.30 billion, with the most recent change of +$40.00 million (+1.71%) on 30 September 2024. Over the past year, it has increased by +$645.00 million (+21.93%). ABT TTM CFI is now -374.31% below its all-time high of $837.00 million, reached on 31 March 2016.ABT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABT Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -80.1% | +6.3% | +21.9% |
| 3 y3 years | -41.4% | +8.8% | -11.0% |
| 5 y5 years | -131.1% | -37.5% | -26.0% |
ABT Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -80.1% | at low | -125.0% | +51.0% | -31.9% | +26.7% |
| 5 y | 5 years | -131.1% | at low | -125.0% | +51.0% | -31.9% | +26.7% |
| alltime | all time | -574.0% | +74.3% | -133.7% | +92.2% | -374.3% | +81.2% |
Abbott Laboratories Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$594.00 M(+31.1%) | -$2.30 B(-1.7%) |
| June 2024 | - | -$453.00 M(+6.6%) | -$2.34 B(-24.5%) |
| Mar 2024 | - | -$425.00 M(-48.4%) | -$3.10 B(-1.2%) |
| Dec 2023 | -$3.13 B(+80.1%) | -$824.00 M(+30.0%) | -$3.13 B(+6.5%) |
| Sept 2023 | - | -$634.00 M(-47.7%) | -$2.94 B(+5.4%) |
| June 2023 | - | -$1.21 B(+162.6%) | -$2.79 B(+51.5%) |
| Mar 2023 | - | -$462.00 M(-26.9%) | -$1.84 B(+5.9%) |
| Dec 2022 | -$1.74 B(-13.3%) | -$632.00 M(+30.6%) | -$1.74 B(-2.2%) |
| Sept 2022 | - | -$484.00 M(+83.3%) | -$1.78 B(-8.6%) |
| June 2022 | - | -$264.00 M(-26.7%) | -$1.95 B(0.0%) |
| Mar 2022 | - | -$360.00 M(-46.3%) | -$1.95 B(-3.1%) |
| Dec 2021 | -$2.01 B(-9.3%) | -$671.00 M(+3.1%) | -$2.01 B(-2.9%) |
| Sept 2021 | - | -$651.00 M(+146.6%) | -$2.07 B(+9.5%) |
| June 2021 | - | -$264.00 M(-37.4%) | -$1.89 B(-15.8%) |
| Mar 2021 | - | -$422.00 M(-42.3%) | -$2.24 B(+1.3%) |
| Dec 2020 | -$2.21 B(+22.0%) | -$731.00 M(+54.9%) | -$2.21 B(+12.3%) |
| Sept 2020 | - | -$472.00 M(-23.7%) | -$1.97 B(+2.1%) |
| June 2020 | - | -$619.00 M(+57.5%) | -$1.93 B(+6.7%) |
| Mar 2020 | - | -$393.00 M(-19.6%) | -$1.81 B(-0.2%) |
| Dec 2019 | -$1.81 B(+33.8%) | -$489.00 M(+13.2%) | -$1.81 B(-0.4%) |
| Sept 2019 | - | -$432.00 M(-13.3%) | -$1.82 B(+6.4%) |
| June 2019 | - | -$498.00 M(+25.8%) | -$1.71 B(+13.1%) |
| Mar 2019 | - | -$396.00 M(-20.2%) | -$1.51 B(+11.7%) |
| Dec 2018 | -$1.36 B(-85.9%) | -$496.00 M(+53.6%) | -$1.36 B(-66.2%) |
| Sept 2018 | - | -$323.00 M(+8.0%) | -$4.01 B(+0.4%) |
| June 2018 | - | -$299.00 M(+25.6%) | -$4.00 B(+7.9%) |
| Mar 2018 | - | -$238.00 M(-92.4%) | -$3.70 B(-61.5%) |
| Dec 2017 | -$9.62 B(+3778.2%) | -$3.15 B(+930.1%) | -$9.62 B(+95.6%) |
| Sept 2017 | - | -$306.00 M(+5000.0%) | -$4.92 B(-4.8%) |
| June 2017 | - | -$6.00 M(-99.9%) | -$5.16 B(-22.1%) |
| Mar 2017 | - | -$6.15 B(-497.0%) | -$6.63 B(+2572.6%) |
| Dec 2016 | -$248.00 M(-161.1%) | $1.55 B(-379.8%) | -$248.00 M(+6.9%) |
| Sept 2016 | - | -$554.00 M(-62.3%) | -$232.00 M(-73.5%) |
| June 2016 | - | -$1.47 B(-750.4%) | -$875.00 M(-204.5%) |
| Mar 2016 | - | $226.00 M(-85.6%) | $837.00 M(+106.2%) |
| Dec 2015 | $406.00 M(-301.0%) | $1.57 B(-230.8%) | $406.00 M(-134.7%) |
| Sept 2015 | - | -$1.20 B(-594.6%) | -$1.17 B(+46.6%) |
| June 2015 | - | $242.00 M(-218.0%) | -$798.00 M(-524.5%) |
| Mar 2015 | - | -$205.00 M(+1950.0%) | $188.00 M(-193.1%) |
| Dec 2014 | -$202.00 M(-94.9%) | -$10.00 M(-98.8%) | -$202.00 M(-131.2%) |
| Sept 2014 | - | -$825.00 M(-167.2%) | $648.00 M(-152.9%) |
| June 2014 | - | $1.23 B(-306.4%) | -$1.22 B(-49.3%) |
| Mar 2014 | - | -$595.00 M(-170.8%) | -$2.42 B(-38.5%) |
| Dec 2013 | -$3.93 B(-29.3%) | $840.00 M(-131.1%) | -$3.93 B(-34.5%) |
| Sept 2013 | - | -$2.70 B(-7591.7%) | -$5.99 B(+74.8%) |
| June 2013 | - | $36.00 M(-101.7%) | -$3.43 B(+23.5%) |
| Mar 2013 | - | -$2.11 B(+72.1%) | -$2.78 B(-50.1%) |
| Dec 2012 | -$5.56 B(-941.1%) | -$1.22 B(+830.8%) | -$5.56 B(+116.3%) |
| Sept 2012 | - | -$131.61 M(-119.1%) | -$2.57 B(+77.7%) |
| June 2012 | - | $688.37 M(-114.1%) | -$1.45 B(-25.0%) |
| Mar 2012 | - | -$4.89 B(-377.2%) | -$1.93 B(-391.9%) |
| Dec 2011 | $661.00 M(-105.4%) | $1.76 B(+77.9%) | $661.00 M(-118.7%) |
| Sept 2011 | - | $992.00 M(+382.5%) | -$3.54 B(-48.9%) |
| June 2011 | - | $205.59 M(-108.9%) | -$6.93 B(+1.4%) |
| Mar 2011 | - | -$2.30 B(-5.7%) | -$6.83 B(-44.0%) |
| Dec 2010 | -$12.19 B(+229.5%) | -$2.44 B(+2.0%) | -$12.19 B(+48.9%) |
| Sept 2010 | - | -$2.39 B(-887.6%) | -$8.19 B(+12.0%) |
| June 2010 | - | $303.83 M(-104.0%) | -$7.31 B(-25.0%) |
| Mar 2010 | - | -$7.66 B(-590.0%) | -$9.75 B(+163.7%) |
| Dec 2009 | -$3.70 B(+77.2%) | $1.56 B(-202.9%) | -$3.70 B(-34.1%) |
| Sept 2009 | - | -$1.52 B(-29.0%) | -$5.61 B(+35.3%) |
| June 2009 | - | -$2.14 B(+33.1%) | -$4.15 B(+48.2%) |
| Mar 2009 | - | -$1.61 B(+355.9%) | -$2.80 B(+34.1%) |
| Dec 2008 | -$2.09 B(+83.7%) | -$352.19 M(+551.0%) | -$2.09 B(+6.3%) |
| Sept 2008 | - | -$54.10 M(-93.1%) | -$1.96 B(-13.4%) |
| June 2008 | - | -$788.04 M(-11.8%) | -$2.27 B(+38.2%) |
| Mar 2008 | - | -$893.16 M(+291.1%) | -$1.64 B(+44.4%) |
| Dec 2007 | -$1.14 B | -$228.36 M(-36.3%) | -$1.14 B(-76.5%) |
| Sept 2007 | - | -$358.28 M(+123.0%) | -$4.83 B(-0.1%) |
| June 2007 | - | -$160.66 M(-58.7%) | -$4.83 B(-57.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | -$388.98 M(-90.1%) | -$11.49 B(+0.8%) |
| Dec 2006 | -$11.40 B(+1482.8%) | -$3.92 B(+975.4%) | -$11.40 B(+41.8%) |
| Sept 2006 | - | -$364.58 M(-94.7%) | -$8.04 B(+1.0%) |
| June 2006 | - | -$6.82 B(+2233.0%) | -$7.96 B(+467.0%) |
| Mar 2006 | - | -$292.33 M(-48.0%) | -$1.40 B(+94.9%) |
| Dec 2005 | -$720.09 M(-81.9%) | -$561.64 M(+98.6%) | -$720.09 M(+20.6%) |
| Sept 2005 | - | -$282.76 M(+6.1%) | -$597.21 M(+2.1%) |
| June 2005 | - | -$266.49 M(-168.2%) | -$584.64 M(-75.0%) |
| Mar 2005 | - | $390.80 M(-189.1%) | -$2.34 B(-41.2%) |
| Dec 2004 | -$3.98 B(+177.1%) | -$438.76 M(+62.4%) | -$3.98 B(-1.0%) |
| Sept 2004 | - | -$270.20 M(-86.6%) | -$4.02 B(-3.5%) |
| June 2004 | - | -$2.02 B(+61.7%) | -$4.17 B(+72.3%) |
| Mar 2004 | - | -$1.25 B(+161.1%) | -$2.42 B(+68.4%) |
| Dec 2003 | -$1.44 B(-15.0%) | -$478.96 M(+15.0%) | -$1.44 B(+27.6%) |
| Sept 2003 | - | -$416.57 M(+52.4%) | -$1.13 B(+7.1%) |
| June 2003 | - | -$273.26 M(+1.8%) | -$1.05 B(-36.7%) |
| Mar 2003 | - | -$268.39 M(+59.4%) | -$1.66 B(-1.6%) |
| Dec 2002 | -$1.69 B(-79.8%) | -$168.33 M(-50.8%) | -$1.69 B(-20.2%) |
| Sept 2002 | - | -$342.14 M(-61.3%) | -$2.12 B(-10.5%) |
| June 2002 | - | -$884.39 M(+199.0%) | -$2.37 B(+15.5%) |
| Mar 2002 | - | -$295.81 M(-50.3%) | -$2.05 B(-75.6%) |
| Dec 2001 | -$8.38 B(+1257.5%) | -$595.38 M(+0.7%) | -$8.38 B(+4.4%) |
| Sept 2001 | - | -$591.13 M(+4.2%) | -$8.03 B(+7.5%) |
| June 2001 | - | -$567.08 M(-91.4%) | -$7.47 B(+4.5%) |
| Mar 2001 | - | -$6.63 B(+2661.2%) | -$7.15 B(+1057.2%) |
| Dec 2000 | -$617.66 M(-48.5%) | -$240.16 M(+671.2%) | -$617.66 M(-22.8%) |
| Sept 2000 | - | -$31.14 M(-87.3%) | -$799.91 M(-31.3%) |
| June 2000 | - | -$244.91 M(+141.4%) | -$1.17 B(-1.7%) |
| Mar 2000 | - | -$101.45 M(-76.0%) | -$1.19 B(-1.0%) |
| Dec 1999 | -$1.20 B(-18.6%) | -$422.41 M(+6.6%) | -$1.20 B(+1.9%) |
| Sept 1999 | - | -$396.29 M(+49.3%) | -$1.18 B(+20.1%) |
| June 1999 | - | -$265.48 M(+132.8%) | -$978.78 M(-28.5%) |
| Mar 1999 | - | -$114.02 M(-71.5%) | -$1.37 B(-7.0%) |
| Dec 1998 | -$1.47 B(+18.5%) | -$400.20 M(+101.0%) | -$1.47 B(+5.8%) |
| Sept 1998 | - | -$199.09 M(-69.6%) | -$1.39 B(-7.8%) |
| June 1998 | - | -$654.82 M(+201.3%) | -$1.51 B(+19.7%) |
| Mar 1998 | - | -$217.30 M(-31.9%) | -$1.26 B(+1.5%) |
| Dec 1997 | -$1.24 B(-36.5%) | -$319.30 M(+1.0%) | -$1.24 B(-5.6%) |
| Sept 1997 | - | -$316.02 M(-22.4%) | -$1.31 B(+4.6%) |
| June 1997 | - | -$407.16 M(+104.8%) | -$1.26 B(-35.4%) |
| Mar 1997 | - | -$198.82 M(-49.3%) | -$1.94 B(-0.5%) |
| Dec 1996 | -$1.96 B(+88.4%) | -$392.27 M(+51.8%) | -$1.96 B(+11.2%) |
| Sept 1996 | - | -$258.33 M(-76.4%) | -$1.76 B(-0.3%) |
| June 1996 | - | -$1.10 B(+423.0%) | -$1.76 B(+107.2%) |
| Mar 1996 | - | -$209.40 M(+7.2%) | -$851.00 M(-18.0%) |
| Dec 1995 | -$1.04 B(+9.9%) | -$195.30 M(-26.0%) | -$1.04 B(+0.3%) |
| Sept 1995 | - | -$263.78 M(+44.5%) | -$1.03 B(-2.5%) |
| June 1995 | - | -$182.51 M(-53.9%) | -$1.06 B(-4.8%) |
| Mar 1995 | - | -$396.13 M(+105.8%) | -$1.11 B(+18.1%) |
| Dec 1994 | -$944.09 M(+18.9%) | -$192.49 M(-33.6%) | -$944.09 M(+10.6%) |
| Sept 1994 | - | -$290.07 M(+22.8%) | -$853.34 M(+11.8%) |
| June 1994 | - | -$236.24 M(+4.9%) | -$763.17 M(-2.2%) |
| Mar 1994 | - | -$225.29 M(+121.4%) | -$780.13 M(-1.7%) |
| Dec 1993 | -$793.84 M(+18.9%) | -$101.74 M(-49.1%) | -$793.84 M(-17.0%) |
| Sept 1993 | - | -$199.90 M(-21.1%) | -$956.20 M(-4.4%) |
| June 1993 | - | -$253.20 M(+5.9%) | -$999.80 M(+50.4%) |
| Mar 1993 | - | -$239.00 M(-9.5%) | -$664.70 M(-0.4%) |
| Dec 1992 | -$667.60 M(+4.0%) | -$264.10 M(+8.5%) | -$667.60 M(+2.2%) |
| Sept 1992 | - | -$243.50 M(-397.3%) | -$653.40 M(+11.5%) |
| June 1992 | - | $81.90 M(-133.9%) | -$586.10 M(-33.8%) |
| Mar 1992 | - | -$241.90 M(-3.2%) | -$885.90 M(+38.0%) |
| Dec 1991 | -$642.10 M(+3.8%) | -$249.90 M(+41.8%) | -$642.10 M(+56.5%) |
| Sept 1991 | - | -$176.20 M(-19.1%) | -$410.30 M(+2.9%) |
| June 1991 | - | -$217.90 M(<-9900.0%) | -$398.70 M(-7.4%) |
| Mar 1991 | - | $1.90 M(-110.5%) | -$430.60 M(-30.4%) |
| Dec 1990 | -$618.30 M(+57.6%) | -$18.10 M(-89.0%) | -$618.30 M(+3.0%) |
| Sept 1990 | - | -$164.60 M(-34.1%) | -$600.20 M(+37.8%) |
| June 1990 | - | -$249.80 M(+34.4%) | -$435.60 M(+134.4%) |
| Mar 1990 | - | -$185.80 M | -$185.80 M |
| Dec 1989 | -$392.20 M | - | - |
FAQ
- What is Abbott Laboratories annual cash flow from investing activities?
- What is the all time high annual CFI for Abbott Laboratories?
- What is Abbott Laboratories annual CFI year-on-year change?
- What is Abbott Laboratories quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Abbott Laboratories?
- What is Abbott Laboratories quarterly CFI year-on-year change?
- What is Abbott Laboratories TTM cash flow from investing activities?
- What is the all time high TTM CFI for Abbott Laboratories?
- What is Abbott Laboratories TTM CFI year-on-year change?
What is Abbott Laboratories annual cash flow from investing activities?
The current annual CFI of ABT is -$3.13 B
What is the all time high annual CFI for Abbott Laboratories?
Abbott Laboratories all-time high annual cash flow from investing activities is $661.00 M
What is Abbott Laboratories annual CFI year-on-year change?
Over the past year, ABT annual cash flow from investing activities has changed by -$1.39 B (-80.06%)
What is Abbott Laboratories quarterly cash flow from investing activities?
The current quarterly CFI of ABT is -$594.00 M
What is the all time high quarterly CFI for Abbott Laboratories?
Abbott Laboratories all-time high quarterly cash flow from investing activities is $1.76 B
What is Abbott Laboratories quarterly CFI year-on-year change?
Over the past year, ABT quarterly cash flow from investing activities has changed by +$40.00 M (+6.31%)
What is Abbott Laboratories TTM cash flow from investing activities?
The current TTM CFI of ABT is -$2.30 B
What is the all time high TTM CFI for Abbott Laboratories?
Abbott Laboratories all-time high TTM cash flow from investing activities is $837.00 M
What is Abbott Laboratories TTM CFI year-on-year change?
Over the past year, ABT TTM cash flow from investing activities has changed by +$645.00 M (+21.93%)